The genetic alterations that cause the development of
glucocorticoid and/or
mineralocorticoid producing benign adrenocortical
tumors and
hyperplasias have largely been elucidated over the past two decades through advances in genomics. In benign
aldosterone-producing adrenocortical
tumors and
hyperplasias, alteration of intracellular calcium signaling has been found to be significant in
aldosterone hypersecretion, with causative defects including those in KCNJ5, ATP1A1, ATP2B3, CACNA1D, CACNA1H, and CLCN2. In benign
cortisol-producing adrenocortical
tumors and
hyperplasias abnormal cyclic
adenosine monophosphate-
protein kinase A signaling has been found to play a central role in
tumorigenesis, with pathogenic variants in GNAS, PRKAR1A, PRKACA, PRKACB, PDE11A, and PDE8B being implicated. The role of this signaling pathway in the development of
Cushing's syndrome and adrenocortical
tumors was initially discovered through the study of the underlying genetic defects causing the rare
multiple endocrine neoplasia syndromes McCune-Albright syndrome and
Carney complex with subsequent identification of defects in genes affecting the cyclic
adenosine monophosphate-
protein kinase A pathway in sporadic
tumors. Additionally, germline pathogenic variants in ARMC5, a putative
tumor suppressor, were found to be a cause of
cortisol-producing primary bilateral macronodular adrenal
hyperplasia. This review describes the genetic causes of benign
cortisol- and
aldosterone-producing adrenocortical
tumors.